Nereid Therapeutics
About Nereid Therapeutics
Nereid Therapeutics utilizes proprietary technologies to measure and visualize liquid-liquid phase separation (LLPS) in mammalian cells, enabling the discovery of small molecules that can modulate protein interactions involved in diseases like cancer and inflammatory disorders. By providing precise insights into biomolecular condensates, the company addresses the challenge of developing effective treatments for intractable diseases that have limited therapeutic options.
```xml <problem> Many diseases, including cancers, neurodegenerative illnesses, and inflammatory disorders, are linked to the formation and function of membrane-less compartments within cells via intracellular liquid-liquid phase separation (LLPS). However, there has been no systematic method to measure intracellular LLPS and determine the impact of therapeutics on this process. </problem> <solution> Nereid Therapeutics is developing therapies by measuring and modulating intracellular LLPS. The company utilizes technologies to illuminate the formation and behavior of biomolecular condensates, enabling the precise measurement of LLPS in mammalian cells. Combined with proprietary microscopy and computer vision, Nereid discovers small molecules that can modulate protein interactions found in disease states. The company's platform integrates soft matter physics, cell biology, machine learning, and medicinal chemistry to discover therapeutics that can modify the phase behavior of living cells. </solution> <features> - Proprietary technologies to measure and visualize LLPS in mammalian cells - Advanced microscopy and computer vision to illuminate the formation and behavior of biomolecular condensates - Discovery of small molecules that modulate protein interactions in disease states - Platform integrates soft matter physics, cell biology, machine learning, and medicinal chemistry </features> <target_audience> The primary target audience includes researchers and pharmaceutical companies focused on developing treatments for cancers, neurodegenerative illnesses, and inflammatory disorders. </target_audience> ```
What does Nereid Therapeutics do?
Nereid Therapeutics utilizes proprietary technologies to measure and visualize liquid-liquid phase separation (LLPS) in mammalian cells, enabling the discovery of small molecules that can modulate protein interactions involved in diseases like cancer and inflammatory disorders. By providing precise insights into biomolecular condensates, the company addresses the challenge of developing effective treatments for intractable diseases that have limited therapeutic options.
Where is Nereid Therapeutics located?
Nereid Therapeutics is based in Boston, United States.
When was Nereid Therapeutics founded?
Nereid Therapeutics was founded in 2020.
How much funding has Nereid Therapeutics raised?
Nereid Therapeutics has raised 50000000.
- Location
- Boston, United States
- Founded
- 2020
- Funding
- 50000000
- Employees
- 14 employees